Literature DB >> 21948166

Application of radiotherapy and chemotherapy protocols to pre-clinical tumor models.

Randy Burd1, Phyllis Wachsberger.   

Abstract

This unit (1) provides background into understanding how agents that target specific molecules or receptors (molecular-targeted agents), in particular, agents affecting the tumor vasculature (perivasculature network in tumors), interact with and modify radiation therapy; (2) details factors affecting interpretation of results in murine tumor model experiments utilizing radiation therapy and drug combinations; and (3) provides specific protocols for the application of radiation therapy, both alone and in combination with chemotherapy and/or molecular-targeted agents.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 21948166     DOI: 10.1002/0471141755.ph1407s38

Source DB:  PubMed          Journal:  Curr Protoc Pharmacol        ISSN: 1934-8282


  2 in total

1.  Metformin inhibits salivary adenocarcinoma growth through cell cycle arrest and apoptosis.

Authors:  Yuqi Guo; Tao Yu; Jian Yang; Tianqing Zhang; Yang Zhou; Fan He; Zoya Kurago; David Myssiorek; Yingjie Wu; Peng Lee; Xin Li
Journal:  Am J Cancer Res       Date:  2015-11-15       Impact factor: 6.166

2.  Custom-designed Small Animal focal iRradiation Jig (SARJ): design, manufacture and dosimetric evaluation.

Authors:  Jothy Selvaraj; Graham Rhall; Mounir Ibrahim; Talat Mahmood; Nigel Freeman; Zennon Gromek; Grant Buchanan; Farhan Syed; Hany Elsaleh; Ben J C Quah
Journal:  BJR Open       Date:  2020-03-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.